Gene Therapy Advisory Committee Research Articles

Gene therapy advisory committee: long-term monitoring of patients participating in gene therapy: Health Departments of the United Kingdom.

Gene therapy advisory committee: long-term monitoring of patients participating in gene therapy: Health Departments of the United Kingdom.

Experience of Gene Therapy in the United Kingdom

The UK Committee on the Ethics of Gene Therapy recommended the establishment of a supervisory body with collective expertise, experience, and authority to regulate gene therapy. In November 1993, the supervisory body, known as the Gene Therapy Advisory Committee (GTAC), was established. It interacts with other bodies, including the Medicines Control Agency, local research ethics committees, the Health and Safety Executive, and the Hospital Trust. When proposals for gene therapy are reviewed, there is careful assessment of the scientific merits, the competence of those undertaking the research, and the risks involved. Each proposal is assessed by several independent expert advisors, in specific aspects of the research. The researchers are apprised of the issues raised by the assessors and given the opportunity to modify their proposals. The research team is then given the opportunity to make a brief presentation to the GTAC. The proposals may be approved subject to conditions, deferred until further issues are resolved, or rejected on the basis that the proposal is unethical or the science unsound. Researchers are expected to provide the committee with regular progress reports. This paper discusses the experience of gene regulation in the United Kingdom.

Gene Therapy Advisory Committee third annual report (January 1996-December 1996). Health departments of the United Kingdom.

Human Gene TherapyVol. 8, No. 18 Special FeatureThird Annual Report (January 1996–December 1996). Health Departments of the United Kingdom Gene Therapy Advisory CommitteePublished Online:20 Mar 2008https://doi.org/10.1089/hum.1997.8.18-2269AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetails Volume 8Issue 18Dec 1997 InformationCopyright 1997, Mary Ann Liebert, Inc.To cite this article:Third Annual Report (January 1996–December 1996). Health Departments of the United Kingdom Gene Therapy Advisory Committee.Human Gene Therapy.Dec 1997.2269-2279.http://doi.org/10.1089/hum.1997.8.18-2269Published in Volume: 8 Issue 18: March 20, 2008PDF download

Second annual report January 1995-December 1995 Health Departments of the United Kingdom Gene Therapy Advisory Committee May 1996.

Second annual report January 1995-December 1995 Health Departments of the United Kingdom Gene Therapy Advisory Committee May 1996.

Gene Therapy Advisory Committee. Writing information leaflets for patients participating in gene therapy research. Health Departments of the United Kingdom, August 1995.

Human Gene TherapyVol. 7, No. 6 Special FeatureWriting Information Leaflets for Patients Participating in Gene Therapy Research. Report of the Health Departments of the United Kingdom's Gene Therapy Advisory CommitteePublished Online:20 Mar 2008https://doi.org/10.1089/hum.1996.7.6-751AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetails Volume 7Issue 6Apr 1996 InformationCopyright 1996, Mary Ann Liebert, Inc.To cite this article:Writing Information Leaflets for Patients Participating in Gene Therapy Research. Report of the Health Departments of the United Kingdom's Gene Therapy Advisory Committee.Human Gene Therapy.Apr 1996.751-754.http://doi.org/10.1089/hum.1996.7.6-751Published in Volume: 7 Issue 6: March 20, 2008PDF download

The role of the gene therapy advisory committee in the oversight of gene therapy research in the United Kingdom

The role of the gene therapy advisory committee in the oversight of gene therapy research in the United Kingdom